Rxwire
In the news · 48h FDA 38 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Daiichi Sankyo 2
Deals & business · first seen 22h ago, updated 16h ago

InnoCare inks licensing deal with Eli Lilly worth up to $3.35B

2 outlets Eli Lilly

Eli Lilly has signed up Beijing-based InnoCare to develop new medicines in a partnership that could be worth up to $3.35 billion if the products go on sale. InnoCare will use its in-house drug discovery ...

Summary from Endpoints News.

Coverage 2 articles · 2 outlets

  1. Seeking Alpha Healthcare
    InnoCare inks licensing deal with Eli Lilly worth up to $3.35B
  2. Endpoints News
    In another China pact, Lilly makes a deal with InnoCare worth up to $3.35B